Non-drug methods in the treatment of children with atopic bronchial asthma
- Autores: Asiryan E.G1
-
Afiliações:
- Vitebsk State Order of Peoples' Friendship Medical University
- Edição: Nº 1 (2018)
- Páginas: 48-53
- Seção: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/294503
- ID: 294503
Citar
Texto integral
Acesso aberto
Acesso está concedido
Acesso é pago ou somente para assinantes
Resumo
Purpose. To evaluate the clinical and immunological efficacy of use of ultrasound in combination with autoserotherapy in children with atopic bronchial asthma (BA). Material and Methods. The study included 64 children with atopic asthma aged 6 to 18 years. Group A received ultrasound in combination with autoserotherapy in addition to the background therapy. Group B received background therapy only. During the study, the level of disease control, the use of background therapy, and basophil phenotypes were assessed. Results. In both groups, the disease control has increased in children aged over 12 years; the results of the ACT test at 1 and 3 months were significantly higher in Group A than in Group B (P <0.05). When comparing the results of the test in children aged 6-12 years, the results of the C-ACT test at 1 month were statistically significantly higher in Group A than in Group B (P <0.05), indicating an earlier achievement of control in the group of children who received ultrasound with autoserotherapy in addition to background therapy. After 6 months from the start of treatment, the number of children in need of background therapy was significantly higher in Group B than in Group A (P <0.05). When studying the basophil phenotypes, it was found that in patients receiving ultrasound with autoserotherapy, the relative and absolute levels of basophils carrying CD203c +, CD203c+CD63 + receptor have decreased. In this group of children, the absolute level of CD203c+IgE+ basophils was statistically significantly lower (P <0.05). When comparing the parametres in two groups, it was revealed that the relative level of CD203c + CD63 + basophils was statistically significantly lower in group A than in group B at 82-90 days (P <0.05). Conclusions. The use of ultrasound in combination with autoserotherapy in children with atopic BA contributes to a faster achievement of disease control, shorter use of background therapy, and changes the basophil phenotype, reducing proallergic indicators.
Palavras-chave
Texto integral
Sobre autores
E. Asiryan
Vitebsk State Order of Peoples' Friendship Medical University
Email: lena.asiryn@mail.ru
PhD, Associate Professor at the Department of Pediatrics
Bibliografia
- Шибанова Н.В. Клинико-функциональные и иммунологические подходы к оптимизации лечения бронхиальной астмы у детей. Дисс.. канд. мед. наук. Самара, 2007.
- Lio RA. Non-pharmacologic therapies for atopic dermatitis. Curr. Allergy Asthma Rep. 2013; 13(5): 528-38.
- Хан М.А., Мизерницкий Ю.Л., Лян Н.А. Принципы и современные технологии медицинской реабилитации в детской пульмонологии. Детская и подростковая реабилитация. 2012; 2(19): 53-62.
- Улащик В.С. Иммунокоррекция: использование лечебных физических факторов. Здравоохранение. 2017; 3: 9-17.
- Пономаренко Г.Н., Турковский И.И. Биофизические основы физиотерапии. Учебное пособие. М., 2006. 176 с.
- Новиков Д.К, Новиков П.Д. Клиническая иммунопатология: руководство. М., 2009. 464 с.
- Смирнова О.В., Выхристенко Л.Р. Иммунофизиотерапия бронхиальной астмы. Рецепт. 2011; 1(75): 67-78.
- Гафиятуллина Г.Ш., Омельченко В.П. Физиотерапия: учебное пособие. М., 2010. 280 с.
- Титова Н.Д., Асирян Е.Г. Снижение уровня IgE-антител к аллергенам после аутосеротерапии у детей с аллергией. Иммунопатология, аллергология, инфектология. 2011; 1: 78-86.
- Новиков Д.К., Выхристенко Л.Р., Смирнова О.В. Аутосеротерапия аллергических заболеваний Аллергология и иммунология. 2008; 9(4): 478-80.
- Global Strategy for asthma management and prevention GINA. URL: http://www.slideshare.net/cristobalbunuel/gina-report-2015.
- Асирян Е.Г., Новиков П.Д., Волотовская А.В., Дробыш Я.В. Метод лечения бронхиальной астмы у детей. Инструкция по применению: утв. Минздравом Респ. Беларусь 26.01.2018, регистрационный №008-0118, Витебск, 2018.
- Смирнова О.В., Выхристенко Л.Р. Роль клеток системы иммунитета в патогенезе бронхиальной астмы. Медицинские новости. 2011; 5: 18-29.
- Übel C., Graser A., Koch S., Rieker R.J., Lehr H.A., Müller M., Finotto S. Role of Tyk-2 in Th9 and Th17 cells in allergic asthma. Sci. Rep. 2014; 4: 58-65.
- Kang M.G., Song W.J., Park H.K., Lim K.H., Kim S.J., Lee S.Y., Kim S.H., Cho S.H., Min K.U., Chang YS. Basophil Activation Test with Food Additives in Chronic Urticaria Patients. Clin. Nutr. Res. 2014; 3: 9-16.
- Синельникова Н.А., Бычкова Н.В., Калин-на Н.М. Особенности иммунного ответа и активации базофилов у детей с хронической крапивницей. Медицинская иммунология. 2015; 17(1): 39-46.
Arquivos suplementares
